Purchases and Sales Made in Q4 2024 in Halozyme Therapeutics, Inc. (HALO)
This table provides information about the institutional ownership of Halozyme Therapeutics, Inc. (HALO) during Q4 2024. The information is specifically focused on institutions that hold shares of HALOZYME THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 08, 2025
Q4 2024
|
First Hawaiian Bank
|
BUY
|
- |
20.7K+ 56.17% |
$881K - $1.26M
|
57.6K
$3.04M
|
|
|
Jan 03, 2025
Q4 2024
|
Everence Capital Management Inc
|
BUY
|
- |
5.11KNew |
$218K - $312K
|
5.11K
$270K
|
|
|
Jan 06, 2025
Q4 2024
|
Oliver Luxxe Assets LLC
Gladstone, NJ |
BUY
|
- |
1.56K+ 5.6% |
$66.2K - $95K
|
29.3K
$1.55M
|
|
|
Jan 02, 2025
Q4 2024
|
Versant Capital Management, Inc
|
BUY
|
- |
417+ 1985.71% |
$17.8K - $25.5K
|
438
$23.1K
|
|
|
Jan 02, 2025
Q4 2024
|
Gamma Investing LLC
Foster City, CA |
BUY
|
- |
70+ 8.07% |
$2.98K - $4.28K
|
937
$49.5K
|
|
|
Jan 10, 2025
Q4 2024
|
Harbor Capital Advisors, Inc.
|
BUY
|
- |
13+ 5.63% |
$553 - $794
|
244
$12.9K
|